| Arkadelphia Clinic For Children And Young Adults, Pa | |
|
2850 Twin Rivers Dr Arkadelphia AR 71923-4212 | |
| (870) 246-8036 | |
| (870) 246-7164 |
| Full Name | Arkadelphia Clinic For Children And Young Adults, Pa |
|---|---|
| Speciality | Clinic/Center |
| Location | 2850 Twin Rivers Dr, Arkadelphia, Arkansas |
| Authorized Official Name and Position | Gari M Rucker (DELEGATED OFFICIAL) |
| Authorized Official Contact | 8702468036 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Arkadelphia Clinic For Children And Young Adults, Pa 2850 Twin Rivers Dr Arkadelphia AR 71923-4212 Ph: (870) 246-8036 | Arkadelphia Clinic For Children And Young Adults, Pa 2850 Twin Rivers Dr Arkadelphia AR 71923-4212 Ph: (870) 246-8036 |
| NPI Number | 1467095133 |
|---|---|
| Provider Enumeration Date | 10/24/2019 |
| Last Update Date | 10/24/2019 |
| Medicare PECOS PAC ID | 0244423648 |
|---|---|
| Medicare Enrollment ID | O20190806000248 |
News Archive
The new study shows that the fatigue that marathoners and other extreme athletes feel at the end of a race is caused by a tiny leak inside their muscles that probably also saps the energy from patients with heart failure.
RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Health Quest Systems, Inc., headquartered in LaGrange, New York.
Researchers from the University of Tennessee Health Science Center have received a $4.5 million grant over three years from the Agency for Healthcare Research and Quality (AHRQ) to lead a statewide network of primary care providers, health systems, and academic centers to identify, develop, and implement patient-centered approaches to improve quality of care and outcomes for people with cardiovascular disease.
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
A judge has scheduled a hearing for later this month in a longstanding dispute between Kentucky and a Christians-only health care plan. The case pits the Kentucky Department of Insurance against Medi-Share, a Florida-based cost-sharing ministry that helps to pay medical bills for churchgoers across the country.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467095133 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
The new study shows that the fatigue that marathoners and other extreme athletes feel at the end of a race is caused by a tiny leak inside their muscles that probably also saps the energy from patients with heart failure.
RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Health Quest Systems, Inc., headquartered in LaGrange, New York.
Researchers from the University of Tennessee Health Science Center have received a $4.5 million grant over three years from the Agency for Healthcare Research and Quality (AHRQ) to lead a statewide network of primary care providers, health systems, and academic centers to identify, develop, and implement patient-centered approaches to improve quality of care and outcomes for people with cardiovascular disease.
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
A judge has scheduled a hearing for later this month in a longstanding dispute between Kentucky and a Christians-only health care plan. The case pits the Kentucky Department of Insurance against Medi-Share, a Florida-based cost-sharing ministry that helps to pay medical bills for churchgoers across the country.
› Verified 4 days ago
Student Health And Wellness Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1100 Henderson St, Arkadelphia, AR 71999 Phone: 870-230-5102 | |
Baptist Health Specialty Clinic Arkadelphia Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2915 Cypress Rd Ste D, Arkadelphia, AR 71923 Phone: 870-246-5097 Fax: 870-246-9693 | |
Compass Concierge Healthcare, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2606 Pine St, Arkadelphia, AR 71923 Phone: 870-210-5243 | |
Arkadelphia Medical Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2913 Cypress Rd Ste 100, Arkadelphia, AR 71923 Phone: 870-246-2471 Fax: 870-246-2476 | |
Arkadelphia Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3004 Pine St, Arkadelphia, AR 71923 Phone: 870-246-2471 Fax: 870-246-2476 | |
Baptist Health Family Clinic Arkadelphia Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 416 Main St, Arkadelphia, AR 71923 Phone: 870-246-2431 Fax: 870-246-2434 |